Budesonide treatment for microscopic colitis from immune checkpoint inhibitors

BACKGROUND: Immune checkpoint inhibitors (CPIs) are effective against a variety of malignancies but can be limited by inflammatory toxicities such as enterocolitis. Enterocolitis is typically treated with systemically active glucocorticoids. Endoscopy can stratify patients by the severity of mucosal...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Immunother Cancer
Autors principals: Hughes, Michael S., Molina, Gabriel E., Chen, Steven T., Zheng, Hui, Deshpande, Vikram, Fadden, Riley, Sullivan, Ryan J., Dougan, Michael
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2019
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6839080/
https://ncbi.nlm.nih.gov/pubmed/31699151
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-019-0756-0
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars